Pharma Stocks

A Look at Agios Pharmaceuticals’s Valuation After Mixed Results From RISE UP Mitapivat Trial (AGIO)

Agios Pharmaceuticals (AGIO) released results from its Phase 3 RISE UP study for mitapivat in sickle cell disease. The trial…

Read More »

Takeda Pharmaceutical (TSE:4502): Exploring Valuation as Shares Show Renewed Momentum

Takeda Pharmaceutical (TSE:4502) shares have shown solid momentum recently, gaining around 1% in the past day and 4% over the…

Read More »

Can Stevanato Group’s (STVN) Steady Guidance Sustain Investor Confidence Amid Industry Shifts?

Stevanato Group S.p.A. recently announced its third quarter and nine-month 2025 results, highlighting sales of €303.17 million and net income…

Read More »

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Rockets 25% As Investors Are Less Pessimistic Than Expected

The Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) share price has done very well over the last month, posting an excellent gain of…

Read More »

Why Is Agios Pharmaceuticals Stock Sinking Today? – Agios Pharmaceuticals (NASDAQ:AGIO)

Agios Pharmaceuticals Inc. (NASDAQ:AGIO) stock plunged on Wednesday after the company released topline results from RISE UP Phase 3 data…

Read More »

Nxera Introduces Employee Stock Ownership Plan (J-ESOP) for

Tokyo, Japan and Cambridge, UK, 19 November 2025 – Nxera Pharma Co. Ltd (“Nxera” or “the Company; TSE 4565) announces…

Read More »

Earnings Troubles May Signal Larger Issues for Orchid Pharma (NSE:ORCHPHARMA) Shareholders

Last week’s earnings announcement from Orchid Pharma Limited (NSE:ORCHPHARMA) was disappointing to investors, with a sluggish profit figure. Our analysis…

Read More »

Why Big Pharma Won’t Quit the Diet. Who Will Win the Next Weight Loss Battle?

Chances are you know someone on a weight loss injectable. In fact, nearly 12% of Americans are using, or have…

Read More »

Why Is Arrowhead Pharma Stock Soaring Tuesday? – Arrowhead Pharma (NASDAQ:ARWR)

The U.S. Food and Drug Administration (FDA) has approved Arrowhead Pharmaceuticals, Inc.’s (NASDAQ:ARWR) Redemplo (plozasiran), a small interfering RNA (siRNA)…

Read More »

Terns Pharmaceuticals (TERN) Soars to New Record High of $26.12

We recently published 10 Firms Shining Bright in a Bleeding Market. Terns Pharmaceuticals, Inc. (NASDAQ:TERN) is one of the best-performing…

Read More »